Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality

Cancer Letters

Volumn 235, Issue 1, 2006, Pages 130-135

  Panani, Anna D ^a   Roussos, Charis ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Chromosomes; G banding; Ovarian cancer; Recurrent structural chromosomal abnormalities

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 17Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME BANDING PATTERN; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; CHROMOSOME STRUCTURE; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FEMALE; GENETIC IDENTIFICATION; HUMAN; HUMAN CELL; ISOCHROMOSOME; OVARY ADENOCARCINOMA; OVARY CANCER; PRIORITY JOURNAL; STRUCTURAL CHROMOSOME ABERRATION;

ADENOCARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; ISOCHROMOSOMES; KARYOTYPING; NEOPLASM STAGING; OVARIAN NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 33646472561     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.04.010     Document Type: Article

References (24)

1. Lynch H.T., Casey M.J., Lynch J., White T.E., and Godwin A.K. Genetics and ovarian carcinoma. Semin. Oncol. 25 (1998) 265-280
2. Wang N. Cytogenetics and molecular genetics of ovarian cancer. Am. J. Med. Genet. (Semin. Med. Genet.) 115 (2002) 157-163
3. Taetle R., Aickin M., Yang J.-M., Panda L., Emerson J., Roe D., et al. Chromosome abnormalities in ovarian adenocarcinoma: I. Nonrandom chromosome abnormalities from 244 cases. Genes Chromosomes Cancer 25 (1999) 290-300
4. Pejovic T., Heim S., Mandahl N., Baldetorp B., Elmfors B., Floderus U.M., et al. Chromosome aberrations in 35 primary ovarian carcinomas. Genes Chromosomes Cancer 4 (1992) 58-68
5. Thompson F.H., Emerson J., Alberts D., Liu Y., Guan X.Y., Burgess A., et al. Clonal chromosome abnormalities in 54 cases of ovarian carcinoma. Cancer Genet. Cytogenet. 73 (1994) 33-45
6. Jenkins R.B., Bartelt Jr. D., Stalboerger P., Persons D., Dahl R.J., Podratz K., et al. Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet. Cytogenet. 71 (1991) 76-86
7. Thompson F.H., Taetle R., Trent J.M., Liu Y., Massey-Brown K., Scott K.M., et al. Band 1p36 abnormalities and t(1;17) in ovarian carcinoma. Cancer Genet. Cytogenet. 96 (1997) 106-110
8. F. Mitelman, B. Johansson, F. Mertens, Mitelman Database of Chromosome Aberration in Cancer (2004) http://cgap.nci.nih.gov./Chromosomes/Mitelman.
9. Bayani J., Brenton J.D., Macgrecor P.F., Beheshti B., Albert M., Nallainathan D., et al. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridisation and expression microarrays. Cancer Res. 62 (2002) 3466-3476
10. Hu J., Khanna V., Jones M.W., and Surti U. Comparative study of primary and recurrent ovarian serous carcinomas: comparative genomic hybridisation analysis with a potential application for prognosis. Gynecol. Oncol. 89 (2003) 369-375
11. Sham J.S.T., Tang T.C.M., Fang Y., Sun L., Qin L.-X., Wu Q.-L., et al. Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women. Cancer Genet. Cytogenet. 133 (2002) 39-44
12. Israeli O., Gotlieb W.H., Friedman E., Korach J., Friedman E., Goldman B., et al. Genomic analyses of primary and metastatic serous epithelial ovarian cancer. Cancer Genet. Cytogenet. 154 (2004) 16-21
13. Patael-Karasik Y., Danieli M., Gotlieb W.H., Ben-Baruch G., Schiby J., Barakai G., et al. Comparative genomic hybridisation in inherited and sporadic tumors in Israel. Cancer Genet. Cytogenet. 121 (2000) 26-32
14. Rao P.H., Harris C.P., Lu X.Y., Li X.-N., Mok S.C., and Lau C.C. Multicolor spectral karyotyping of serous ovarian adenocarcinoma. Genes Chromosomes Cancer 33 (2002) 123-132
15. In: Mitelman F. (Ed). An International System for Human Cytogenetic Nomenclature (1995), S. Karger, Basel (ISCN 1995)
16. Panani A., and Ferti-Passantonopoulou A. Common marker chromosomes in ovarian cancer. Cancer Genet. Cytogenet. 16 (1985) 65-71
17. Whang-Peng J., Kao-Shan C.S., Lee E.C., Bunn P.A., Carney D.N., Gazdar A.F., et al. Specific chromosome defect associated with human small-cell lung cancer: deletion 3p(14-23). Science 215 (1982) 181-182
18. Launonen V., Mannermaa A., Stenback F., Kosma V.M., Puistola U., Huusko P., et al. Loss of heterozigosity at chromosomes 3,6,8,11,16 and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet. Cytogenet. 122 (2000) 49-54
19. 15 in breast cancer. Cancer Genet. Cytogenet. 51 (1991) 183-188
20. Panani A.D., Ferti A.D., Raptis S.A., and Roussos C. Novel recurrent structural chromosomal aberrations in primary bladder cancer. Anticancer Res. 24 (2004) 2967-2973
21. Thompson F.H., Nelson M.A., Trent J.M., Guan X.Y., Liu Y., Yang J.M., et al. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH and molecular studies. Cancer Genet. Cytogenet. 87 (1996) 55-62
22. Sandberg A.A. Cytogenetics and molecular genetics of bladder cancer: a personal view. Am. J. Med. Genet. (Semin. Med. Genet.) 115 (2002) 173-182
23. Beheshti B., Karaskova J., Park P.C., Squire J.A., and Beatty B.G. Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer cell lines by sequential giemsa banding and spectral karyotyping. Mol. Diagn. 5 (2000) 23-32
24. A.D. Panani, C. Roussos, Non-random structural chromosomal changes in primary gastric cancer, Cancer Lett., (in press).